MAINTENANCE THERAPY WITH LENALIDOMIDE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A POST-HOC ANALYSIS OF THE EMN01 TRIAL

被引：0
|
作者：
Magarotto, V. [1 ]
Bringhen, S. [1 ]
Offidani, M. [2 ]
Benevolo, G. [2 ]
Patriarca, F. [2 ]
Palladino, C. [1 ]
Falcone, A. P. [2 ]
Rossi, D. [2 ]
Villani, O. [2 ]
Musolino, C. [2 ]
Conticello, C. [2 ]
Pulini, S. [2 ]
Omede, P. [1 ]
Zambello, R. [2 ]
Guglielmelli, T. [2 ]
Ledda, A. [2 ]
Liberati, A. M. [2 ]
Hajek, R. [3 ,4 ]
Boccadoro, M. [1 ]
Palumbo, A. [1 ]
机构：
[1] Univ Turin, Div Hematol, Myeloma Unit, Turin, Italy
[2] GIMEMA, Italian Multiple Myeloma Network, Turin, Italy
[3] Univ Ostrava, Fac Med, CZ-70103 Ostrava, Czech Republic
[4] Univ Hosp Ostrava, Dept Haematooncol, Ostrava, Czech Republic
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P271
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [1] Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial
    Bringhen, Sara
    D'Agostino, Mattia
    Paris, Laura
    Ballanti, Stelvio
    Pescosta, Norbert
    Spada, Stefano
    Pezzatti, Sara
    Grasso, Mariella
    Rota-Scalabrini, Delia
    De Rosa, Luca
    Pavone, Vincenzo
    Gazzera, Giulia
    Aquino, Sara
    Poggiu, Marco
    Santoro, Armando
    Gentile, Massimo
    Baldini, Luca
    Petrucci, Maria Teresa
    Tosi, Patrizia
    Marasca, Roberto
    Cellini, Claudia
    Palumbo, Antonio
    Falco, Patrizia
    Hajek, Roman
    Boccadoro, Mario
    Larocca, Alessandra
    HAEMATOLOGICA, 2020, 105 (07) : 1937 - 1947
  • [2] EFFICACY AND SAFETY OF 3 LENALIDOMIDE-BASED COMBINATIONS IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS: RESULTS FROM THE PHASE 3 COMMUNITY BASED EMN01 TRIAL
    Gay, F.
    Bringhen, S.
    Offidani, M.
    Liberati, A.
    Cellini, C.
    Magarotto, V.
    Benevolo, G.
    Aitoro, G.
    Patriarca, F.
    Omede, P.
    Conticello, C.
    Montefusco, Vi
    Rossi, D.
    Palladino, C.
    Pour, L.
    Allegra, A.
    Pietrantuono, G.
    Falcone, A.
    Rocci, A.
    Zambello, R.
    Ledda, A.
    Gentili, S.
    Musto, P.
    Boccadoro, M.
    Hajek, R.
    Palumbo, A.
    HAEMATOLOGICA, 2013, 98 : 95 - 96
  • [3] Efficacy and Safety of Ixazomib Induction and Maintenance in Newly Diagnosed Multiple Myeloma Patients According to the IMWG Frailty Score: A Post-Hoc Analysis of the EMN10-Unito Trial
    Mina, Roberto
    Larocca, Alessandra
    Offidani, Massimo
    Innao, Vanessa
    Cellini, Claudia
    Galli, Monica
    Cetani, Giusy
    Grasso, Mariella
    Ciccone, Giovannino
    Capra, Andrea
    Aquino, Sara
    Priola, Claudia
    Casaluci, Gloria Margiotta
    De Sabbata, Giovanni
    Ballanti, Stelvio
    Cavo, Michele
    Boccadoro, Mario
    Bringhen, Sara
    BLOOD, 2020, 136
  • [4] EFFICACY AND SAFETY OF IXAZOMIB INDUCTION AND MAINTENANCE IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS ACCORDING TO THE IMWG FRAILTY SCORE: A POST-HOC ANALYSIS OF THE EMN10-UNITO TRIAL
    Bonello, F.
    Mina, R.
    Perrone, G.
    Cascavilla, N.
    Liberati, A. M.
    Pescosta, N.
    Fazio, F.
    Ciccone, G.
    Capra, A.
    Patriarca, F.
    Rota-Scalabrini, D.
    Gerace, D.
    Cea, M.
    Zambello, R.
    Monaco, F.
    Belotti, A.
    Cellini, C.
    Stefanoni, P.
    Celeghini, I.
    Aquino, S.
    Casaluci, G. Margiotta
    De Sabbata, G.
    Ballanti, S.
    Offidani, M.
    Bringhen, S.
    Cavo, M.
    Boccadoro, M.
    Larocca, A.
    HAEMATOLOGICA, 2021, 106 (10) : 94 - 95
  • [5] Maintenance Therapy With Lenalidomide Significantly Improved Survival Of Yong Newly Diagnosed Multiple Myeloma Patients
    Gay, Francesca
    Cavallo, Federica
    Caravita, Tommaso
    Cavalli, Maide
    Nagler, Arnon
    Montefusco, Vittorio
    Pogliani, Enrico Maria
    Buttignol, Silvia
    Zamagni, Elena
    Palladino, Carmela
    Marcatti, Magda
    Musto, Pellegrino
    Catalano, Lucio
    Baraldi, Anna
    Carella, Angelo Michele
    Afro, Anna Maria
    Siniscalchi, Agostina
    Crippa, Claudia
    Vallone, Letizia Maria
    Ciccone, Giovannino
    Ben Yehuda, Dina
    Di Raimondo, Francesco
    Hardan, Izhar
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2013, 122 (21)
  • [6] Lenalidomide: A Review in Newly Diagnosed Multiple Myeloma as Maintenance Therapy After ASCT
    Syed, Yahiya Y.
    DRUGS, 2017, 77 (13) : 1473 - 1480
  • [7] Lenalidomide: A Review in Newly Diagnosed Multiple Myeloma as Maintenance Therapy After ASCT
    Yahiya Y. Syed
    Drugs, 2017, 77 : 1473 - 1480
  • [8] Lenalidomide and Dexamethasone Therapy in Elderly Patients with Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of Lenalidomide
    Kobayashi, Takahiro
    Miura, Masatomo
    Niioka, Takenori
    Fujioka, Yuki
    Abumiya, Maiko
    Yoshioka, Tomoko
    Kameoka, Yoshihiro
    Nishikawa, Hiroyoshi
    Takahashi, Naoto
    BLOOD, 2017, 130
  • [9] Lenalidomide as maintenance for every newly diagnosed patient with multiple myeloma
    Mateos, Maria-Victoria
    Gonzalez de la Calle, Veronica
    LANCET ONCOLOGY, 2019, 20 (01): : 5 - 6
  • [10] Lenalidomide (LEN)-melphalan-prednisone induction followed by LEN maintenance (MPR-R) in newly diagnosed multiple myeloma (NDMM) elderly patients (Pts) with moderate renal impairment (RI): MM-015 trial post-hoc analysis
    Catalano, John V.
    Palumbo, Antonio
    Weisel, Katja C.
    Dimopoulos, Meletios A.
    Delforge, Michel
    Blade, Joan
    Petrucci, Maria Teresa
    Kropff, Martin
    Hajek, Roman
    Jacques, Christian
    Yu, Zhinuan
    Herbein, Lindsay
    Cavo, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345